glipizide has been researched along with Cardiac Output, Low in 1 studies
Glipizide: An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
glipizide : An N-sulfonylurea that is glyburide in which the (5-chloro-2-methoxybenzoyl group is replaced by a (5-methylpyrazin-2-yl)carbonyl group. An oral hypoglycemic agent, it is used in the treatment of type 2 diabetes mellitus.
Cardiac Output, Low: A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
Excerpt | Relevance | Reference |
---|---|---|
"Glipizide therapy also was ineffective in improving plasma insulin levels, which were significantly depressed in the diabetic group." | 1.29 | Effects of chronic glipizide treatment on the NIDD heart. ( Schaffer, SW; Warner, BA; Wilson, GL, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schaffer, SW | 1 |
Warner, BA | 1 |
Wilson, GL | 1 |
1 other study available for glipizide and Cardiac Output, Low
Article | Year |
---|---|
Effects of chronic glipizide treatment on the NIDD heart.
Topics: Animals; Animals, Newborn; Blood Glucose; Cardiac Output, Low; Diabetes Mellitus, Experimental; Diab | 1993 |